Immunoendocrine interactions during chronic cysticercosis determine male mouse feminization: role of IL-6.
Taenia crassiceps cysticercosis results in an impressive feminization in male mice during chronic infection, characterized by increased serum estradiol levels 100 times their normal values, while those of testosterone and dihydrotestosterone are decreased by 85 and 95% respectively. Concomitantly, the levels of follicle-stimulating hormone and IL-6 are increased 70 and 90 times their normal values in the infected male mice. Since a specific Th1/Th2 shift of the immune response has been previously reported during the chronic infection, and this shift may be associated with the feminization process, we proposed that this shift is induced by immunoendocrine interactions during the disease, and this gives way to a change in the initial resistance to the infection in the male mice, which become as susceptible as female mice. To confirm this hypothesis, we depleted immune system activity in two different ways: total body irradiation and neonatal thymectomy. Our results show that when immune system activity is depleted using either strategy, the male mice do not feminize, and the levels of follicle-stimulating hormone and IL-6 are inhibited. Depletion of IL-6 using IL-6(-/-) knockout mice does not produce the feminization process stated above, while restitution of the IL-6(-/-) knockout, irradiated, and thymectomized mice with murine recombinant IL-6 restores the feminization process. Expression of the IL-6 gene was found only in the testes and spleen of infected animals. Our results illustrate the importance of immunoendocrine interactions during a parasitic disease and show a possible new mechanism of parasite establishment in an initially resistant host.
Morales-Montor
J
J
Department of Cellular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30606, USA. jmontor66@hotmail.com
Baig
S
S
Mitchell
R
R
Deway
K
K
Hallal-Calleros
C
C
Damian
R T
RT
D000818:Animals; D000909:Antibodies, Helminth / Q000097:blood; D002908:Chronic Disease; D003551:Cysticercosis / Q000150:complications / Q000276:immunology*; D013196:Dihydrotestosterone / Q000097:blood; D004703:Endocrine System / Q000502:physiology; D004958:Estradiol / Q000097:blood; D005262:Feminization / Q000150:complications / Q000276:immunology*; D005640:Follicle Stimulating Hormone / Q000097:blood; D007107:Immune System / Q000502:physiology; D007111:Immunity, Cellular; D015850:Interleukin-6 / Q000097:blood* / Q000235:genetics; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008954:Models, Biological; D013154:Spleen / Q000276:immunology; D013737:Testis / Q000276:immunology; D013739:Testosterone / Q000097:blood
D000909:Antibodies, Helminth; D015850:Interleukin-6; D013196:Dihydrotestosterone; D013739:Testosterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone